TheraCoat was founded by prominent onco-urologists and medical devices professional in May 2004 as an incubator company with initial funding from the Israeli Chief Scientist. TheraCoat Ltd. is a medical application company developing biodegradable drug delivery systems for a local treatment in internal cavities. TheraCoat first application is a slow release chemotherapy intravesical instillation for Superficial Bladder Cancer.